Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Profiting off Near Fatalities: Mylan Inc.’s EpiPen Price-Gouge
Document Type
Blog Post
Publication Date
9-19-2017
Notes/Citation Information
Samuel L. Hoops, Profiting off Near Fatalities: Mylan Inc.’s EpiPen Price-Gouge, The KLJ Blog (Sept. 19, 2017), https://perma.cc/U9SQ-9ZAQ.